Anpuanandam Khanmani, Selvarajah Gayathri Thevi, Choy Mandy Mun Kei, Ng Shing Wei, Kumar Kiven, Ali Razana Mohd, Rajendran Sujey Kumar, Ho Kok Lian, Tan Wen Siang
Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Selangor, 43400 UPM, Serdang, Malaysia.
Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, Malaysia.
BMC Vet Res. 2021 Jan 6;17(1):9. doi: 10.1186/s12917-020-02700-0.
A new domestic cat hepadnavirus (DCH, family Hepadnaviridae) was first reported from whole blood samples of domestic cats in Australia in 2018, and from cat serum samples in Italy in 2019. The pathogenesis of DCH is unknown, but it was reported in cats with viraemia (6.5-10.8%), chronic hepatitis (43%) and hepatocellular carcinoma (28%). Recent reports suggest that DCH resembles the human hepatitis B virus (HBV) and its related hepatopathies. This study aims to detect and characterize DCH among domestic cats in Malaysia. A cross-sectional study was performed on 253 cats, of which 87 had paired blood and liver samples, entailing whole-genome sequencing and phylogenetic analysis of DCH from a liver tissue sample.
Among the 253 cats included in this study, 12.3% of the whole blood samples tested positive for DCH. The detection rate was significantly higher in pet cats (16.6%, n = 24/145) compared to shelter cats (6.5%, n = 7/108). Liver tissues showed higher a DCH detection rate (14.9%, n = 13/87) compared to blood; 5 out of these 13 cats tested positive for DCH in their paired liver and blood samples. Serum alanine transaminase (ALT) was elevated (> 95 units/L) in 12 out of the 23 DCH-positive cats (52.2%, p = 0.012). Whole-genome sequence analysis revealed that the Malaysian DCH strain, with a genome size of 3184 bp, had 98.3% and 97.5% nucleotide identities to the Australian and Italian strains, respectively. The phylogenetic analysis demonstrated that the Malaysian DCH genome was clustered closely to the Australian strain, suggesting that they belong to the same geographically-determined genetic pool (Australasia).
This study provided insights into a Malaysian DCH strain that was detected from a liver tissue. Interestingly, pet cats or cats with elevated ALT were significantly more likely to be DCH positive. Cats with positive DCH detection from liver tissues may not necessarily have viraemia. The impact of this virus on inducing liver diseases in felines warrants further investigation.
一种新型家猫嗜肝DNA病毒(DCH,嗜肝DNA病毒科)于2018年首次在澳大利亚的家猫全血样本中被报道,2019年在意大利的猫血清样本中被报道。DCH的发病机制尚不清楚,但在病毒血症(6.5 - 10.8%)、慢性肝炎(43%)和肝细胞癌(28%)的猫中被报道。最近的报告表明,DCH类似于人类乙型肝炎病毒(HBV)及其相关肝病。本研究旨在检测和鉴定马来西亚家猫中的DCH。对253只猫进行了横断面研究,其中87只猫有配对的血液和肝脏样本,对肝脏组织样本中的DCH进行全基因组测序和系统发育分析。
在本研究纳入的253只猫中,12.3%的全血样本DCH检测呈阳性。宠物猫的检测率(16.6%,n = 24 / 145)显著高于收容所猫(6.5%,n = 7 / 108)。肝脏组织的DCH检测率(14.9%,n = 13 / 87)高于血液;这13只猫中有5只在配对的肝脏和血液样本中DCH检测呈阳性。23只DCH阳性猫中有12只(52.2%,p = 0.012)血清丙氨酸转氨酶(ALT)升高(> 95单位/升)。全基因组序列分析显示,马来西亚DCH毒株基因组大小为3184 bp,与澳大利亚和意大利毒株的核苷酸同源性分别为98.3%和97.5%。系统发育分析表明,马来西亚DCH基因组与澳大利亚毒株紧密聚类,表明它们属于同一地理决定的基因库(澳大拉西亚)。
本研究对从肝脏组织中检测到的马来西亚DCH毒株提供了见解。有趣的是,宠物猫或ALT升高的猫DCH阳性的可能性显著更高。肝脏组织中DCH检测呈阳性的猫不一定有病毒血症。这种病毒对诱导猫肝脏疾病的影响值得进一步研究。